Pausing cancer screening during the severe acute respiratory syndrome coronavirus 2pandemic: Should we revisit the recommendations?

• The outbreak of severe acute respiratory syndrome coronavirus has become a global major concern. • Medical professionals were instructed to use their clinical judgement when scheduling elective activity. • Delays in cancer screening, should not go unnoticed and this ‘knee-jerk’ response should be...

Descripción completa

Detalles Bibliográficos
Autores principales: Amit, Moran, Tam, Samantha, Bader, Tarif, Sorkin, Alex, Benov, Avi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237943/
https://www.ncbi.nlm.nih.gov/pubmed/32473542
http://dx.doi.org/10.1016/j.ejca.2020.04.016
_version_ 1783536429731676160
author Amit, Moran
Tam, Samantha
Bader, Tarif
Sorkin, Alex
Benov, Avi
author_facet Amit, Moran
Tam, Samantha
Bader, Tarif
Sorkin, Alex
Benov, Avi
author_sort Amit, Moran
collection PubMed
description • The outbreak of severe acute respiratory syndrome coronavirus has become a global major concern. • Medical professionals were instructed to use their clinical judgement when scheduling elective activity. • Delays in cancer screening, should not go unnoticed and this ‘knee-jerk’ response should be revisited. • If the current situation last, we anticipate that thousands of cases will be diagnosed late or missed.
format Online
Article
Text
id pubmed-7237943
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-72379432020-05-20 Pausing cancer screening during the severe acute respiratory syndrome coronavirus 2pandemic: Should we revisit the recommendations? Amit, Moran Tam, Samantha Bader, Tarif Sorkin, Alex Benov, Avi Eur J Cancer Article • The outbreak of severe acute respiratory syndrome coronavirus has become a global major concern. • Medical professionals were instructed to use their clinical judgement when scheduling elective activity. • Delays in cancer screening, should not go unnoticed and this ‘knee-jerk’ response should be revisited. • If the current situation last, we anticipate that thousands of cases will be diagnosed late or missed. Elsevier Ltd. 2020-07 2020-05-20 /pmc/articles/PMC7237943/ /pubmed/32473542 http://dx.doi.org/10.1016/j.ejca.2020.04.016 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Amit, Moran
Tam, Samantha
Bader, Tarif
Sorkin, Alex
Benov, Avi
Pausing cancer screening during the severe acute respiratory syndrome coronavirus 2pandemic: Should we revisit the recommendations?
title Pausing cancer screening during the severe acute respiratory syndrome coronavirus 2pandemic: Should we revisit the recommendations?
title_full Pausing cancer screening during the severe acute respiratory syndrome coronavirus 2pandemic: Should we revisit the recommendations?
title_fullStr Pausing cancer screening during the severe acute respiratory syndrome coronavirus 2pandemic: Should we revisit the recommendations?
title_full_unstemmed Pausing cancer screening during the severe acute respiratory syndrome coronavirus 2pandemic: Should we revisit the recommendations?
title_short Pausing cancer screening during the severe acute respiratory syndrome coronavirus 2pandemic: Should we revisit the recommendations?
title_sort pausing cancer screening during the severe acute respiratory syndrome coronavirus 2pandemic: should we revisit the recommendations?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237943/
https://www.ncbi.nlm.nih.gov/pubmed/32473542
http://dx.doi.org/10.1016/j.ejca.2020.04.016
work_keys_str_mv AT amitmoran pausingcancerscreeningduringthesevereacuterespiratorysyndromecoronavirus2pandemicshouldwerevisittherecommendations
AT tamsamantha pausingcancerscreeningduringthesevereacuterespiratorysyndromecoronavirus2pandemicshouldwerevisittherecommendations
AT badertarif pausingcancerscreeningduringthesevereacuterespiratorysyndromecoronavirus2pandemicshouldwerevisittherecommendations
AT sorkinalex pausingcancerscreeningduringthesevereacuterespiratorysyndromecoronavirus2pandemicshouldwerevisittherecommendations
AT benovavi pausingcancerscreeningduringthesevereacuterespiratorysyndromecoronavirus2pandemicshouldwerevisittherecommendations

Ejemplares similares